| CAS Number | 1627091-47-7 |
| Catalog Number | AG01E6U7(AGN-PC-0WNHD4) |
| Chemical Name | rel-3-[6-[(2R,6S)-2,6-Dimethyl-4-morpholinyl]-4-pyrimidinyl]-5-[(1-methylcyclopropyl)oxy]-1H-indazole |
| IUPAC Name | (2R,6S)-2,6-dimethyl-4-[6-[5-(1-methylcyclopropyl)oxy-1H-indazol-3-yl]pyrimidin-4-yl]morpholine |
| InChI | InChI=1S/C21H25N5O2/c1-13-10-26(11-14(2)27-13)19-9-18(22-12-23-19)20-16-8-15(28-21(3)6-7-21)4-5-17(16)24-25-20/h4-5,8-9,12-14H,6-7,10-11H2,1-3H3,(H,24,25)/t13-,14+ |
| InChI Key | ATUUNJCZCOMUKD-OKILXGFUSA-N |
| MDL Number | MFCD30536362 |
| Molecular Formula | C21H25N5O2 |
| Molecular Weight | 379.4555 |
| SMILES | CC1(OC2=CC3=C(NN=C3C4=CC(N5C[C@@H](C)O[C@@H](C)C5)=NC=N4)C=C2)CC1 |
| Synonyms | MLI-2,
1627091-47-7,
(2~{r},6~{s})-2,6-Dimethyl-4-[6-[5-(1-Methylcyclopropyl)oxy-1~{h}-Indazol-3-Yl]pyrimidin-4-Yl]morpholine,
MLi-2 - Bio-X,
CHEMBL4098877,
SCHEMBL16022474,
CHEBI:132484,
AKOS030210950,
CS-6349,
HY-100411,
J3.645.913A,
cis-2,6-dimethyl-4-(6-(5-(1-methylcyclopropoxy)-1H-indazol-3-yl)pyrimidin-4-yl)morpholine,
5-(1-Methylcyclopropane-1-yloxy)-3-[6-(2beta,6beta-dimethylmorpholine-4-yl)pyrimidine-4-yl]-1H-indazole,
A1N,
rel-3-[6-[(2R,6S)-2,6-Dimethyl-4-morpholinyl]-4-pyrimidyl]-5-[(1-methylcyclopropyl)oxy]-1H-indazole,
|
| Complexity | 549 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 379.201g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 28 |
| Hydrogen Bond Acceptor Count | 6 |
| Hydrogen Bond Donor Count | 1 |
| Isotope Atom Count | 0 |
| Molecular Weight | 379.464g/mol |
| Monoisotopic Mass | 379.201g/mol |
| Rotatable Bond Count | 4 |
| Topological Polar Surface Area | 76.2A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 3.2 |
GHS Hazard and Precautionary Statements
| Symbol: | |
|
Hazard statements
|
|
|
Precautionary statements
|
|
Certificate of Analysis
Lot Number